Intended for healthcare professionals

Letters Pregabalin and gabapentin

Misuse of gabapentin and pregabalin may be underestimated

BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5312 (Published 21 November 2017) Cite this as: BMJ 2017;359:j5312
  1. Limon K Nahar, toxicologist1,
  2. Rebecca Andrews, senior toxicologist and deputy head1,
  3. Kevin G Murphy, professor of endocrinology and metabolism2,
  4. Sue Paterson, consultant toxicologist and head1
  1. 1Toxicology Unit, Imperial College London, London W6 8RP, UK
  2. 2Imperial College London, Hammersmith Campus, London W12 0NN, UK
  1. l.nahar{at}imperial.ac.uk

Our data support the government’s decision to reclassify pregabalin and gabapentin to class C controlled substances.1

In the toxicology unit at Imperial College London we conduct toxicology analysis on behalf of coroners throughout London and the South …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription